Patient reporting of adverse drug reactions
admin January 19th, 2009
A member of our unit has written an article on patient reporting of adverse drug reactions at The Pharmaceutical Journal.
Evidence that patient reports complement professional reports of ADRs is growing. Differences in the types of report exist. In particular neuropsychiatric reactions appear to be a particular concern of patients, and it may be that healthcare professionals have been dismissive of this type of report in the past, or that patients may have been less comfortable in reporting such symptoms.
Regulators do value reports from patients, and there is evidence that such reports have contributed to drug safety signals and regulatory decisions, which is the primary purpose of spontaneous reporting schemes such as the yellow card scheme.
- Patient reporting , Publications
- Comments Off